BioRestorative Therapies, Inc. - Common Stock —— 季度资产负债表 (NASDAQ:BRTX) | MetaTrader

展开完整图表完整图表

新闻

What Makes Biorestorative Therapies (BRTX) a New Buy Stock

Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Misses Revenue Estimates

Coherus Oncology (CHRS) Reports Q1 Loss, Lags Revenue Estimates

PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates

Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates

Here's Why Biorestorative Therapies (BRTX) Looks Ripe for Bottom Fishing

Biorestorative Therapies, Inc. (BRTX) Reports Q4 Loss, Lags Revenue Estimates

Absci Corporation (ABSI) Reports Q4 Loss, Misses Revenue Estimates

Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag Estimates

Monte Rosa Therapeutics (GLUE) Reports Q4 Loss, Misses Revenue Estimates

BioRestorative Therapies完成500万美元公开募股

BioRestorative Therapies closes $5 million public offering